Mirum Pharmaceuticals
M$0
21
+M$0+0% Tuesday 11:30
Statistik
Harga Tertinggi Hari
629.79
Harga Terendah Hari
629.79
52M Tertinggi
629.79
52M Terendah
426.02
Volum
0
Volum Purata
138
Kapasiti Pasaran
14.3B
Nisbah P/E
-
Pendapatan Dividen
-
Dividen
-
Akan Datang
Pendapatan
6NovDijangka
EPS yang dijangka
-0.431434
EPS sebenar
N/A
Orang Lain Juga Mengikuti
Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti MIRM.MX. Ini bukan cadangan pelaburan.
Peserta
Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.
Vertex Pharmaceuticals
VRTX
Kapasiti Pasaran127.99B
Alnylam Pharmaceuticals
ALNY
Kapasiti Pasaran33.72B
Gilead Sciences
GILD
Kapasiti Pasaran98.35B
Abbvie
ABBV
Kapasiti Pasaran346.75B
Pfizer
PFE
Kapasiti Pasaran164.39B
Novartis
NVS
Kapasiti Pasaran244.75B
Merck
MRK
Kapasiti Pasaran300.25B
Astrazeneca
AZN
Kapasiti Pasaran271.67B
Bristol-Myers Squibb
BMY
Kapasiti Pasaran101.27B
Mengenai
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.
Show more...
CEO
Mr. Christopher Peetz
Pekerja
194
Negara
United States
ISIN
US6047491013